Bringing efficiencies to clinical trial logistics
UPS has been supporting clinical trials for years, shipping investigational drugs and medical devices as well as patient specimens around the world. Many of its solutions, however, have been custom built for customers as needed. So for the last two years, UPS has focused on how to expand its capabilities for clinical trials and “bolt” those capabilities onto its existing infrastructure, Ron Swistock, UPS director of healthcare strategy, tells PMP News.
As a result of the initiative, UPS has doubled its capacity and can now transport temperature-sensitive products and biological specimens in and out of more than 60 countries more efficiently.
The expansion could potentially meet ongoing industry needs for efficiency. “There are cost pressures on the pharmaceutical industry in general, and substantial costs for clinical trials in terms of logistics,” says Swistock.
Source: Packaging Digest
